Valuation: Bio-Techne Corporation

Market Cap 11.24B 9.82B 9.06B 8.35B 15.74B 1,082B 16.09B 108B 42.61B 530B 42.21B 41.28B 1,825B P/E 2026 *
61.9x
P/E 2027 * 52.3x
Enterprise Value 11.17B 9.76B 9.01B 8.3B 15.65B 1,076B 16B 108B 42.35B 527B 41.95B 41.03B 1,814B EV / Sales 2026 *
9.25x
EV / Sales 2027 * 8.61x
Free-Float
99.69%
Yield 2026 *
0.44%
Yield 2027 * 0.44%

Last Transcript: Bio-Techne Corporation

1 day-0.40%
1 week+1.15%
Current month+2.08%
1 month+24.47%
3 months+21.76%
6 months+5.02%
Current year+22.63%
1 week 71.14
Extreme 71.135
72.12
1 month 55.46
Extreme 55.46
72.12
Current year 43.2
Extreme 43.195
72.16
1 year 43.2
Extreme 43.195
72.16
3 years 43.2
Extreme 43.195
89.91
5 years 43.2
Extreme 43.195
135.96
10 years 23.92
Extreme 23.92
135.96
Manager TitleAgeSince
Chief Executive Officer 59 01/02/2024
Director of Finance/CFO 55 01/04/2014
Chief Tech/Sci/R&D Officer - 06/08/2023
Director TitleAgeSince
Chairman 70 02/11/2012
Director/Board Member 56 19/05/2009
Director/Board Member 63 26/10/2017
Date Insider Type Main position Quantity % Market Cap.
6/2/26 A Fiscal year

Executive/Senior Manager

1,416 0.0009%
5/8/26 A Other

Director

19,908 0.0127%
5/5/26 A Fiscal year

Chief Financial Officer

180,955 0.1157%
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%+1.15%+38.64%-14.02% 11.24B
-0.49%-4.01%+0.61%+2.28% 49.18B
+1.63%-0.39%+386.06%+588.97% 39.58B
+1.67%+4.46%+5.93%+61.54% 34.69B
-0.92%-0.76%+28.41%-8.52% 34.42B
+0.06%+0.34%+2.38%+34.47% 27.11B
+0.69%-3.49% - - 16.21B
-0.50%-0.09%+72.42%+116.45% 15.36B
+0.85%+2.10%+15.23%+18.03% 14.05B
+0.03%+1.36%+18.43%-31.23% 13.02B
Average +0.40%+0.14%+63.12%+85.33% 25.49B
Weighted average by Cap. +0.25%-0.12%+77.76%+115.97%

Financials

2026 *2027 *
Net sales 1.21B 1.06B 974M 898M 1.69B 116B 1.73B 11.65B 4.58B 56.98B 4.54B 4.44B 196B 1.26B 1.1B 1.02B 940M 1.77B 122B 1.81B 12.18B 4.79B 59.62B 4.75B 4.64B 205B
Net income 185M 161M 149M 137M 259M 17.79B 265M 1.78B 700M 8.71B 694M 678M 29.99B 220M 192M 177M 163M 308M 21.17B 315M 2.12B 833M 10.37B 825M 807M 35.68B
Net Debt -68.42M -59.79M -55.18M -50.86M -95.86M -6.59B -97.99M -660M -259M -3.23B -257M -251M -11.11B -352M -308M -284M -262M -494M -33.93B -505M -3.4B -1.34B -16.62B -1.32B -1.29B -57.21B
Logo Bio-Techne Corporation
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools (71.3%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (28.4%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ; - other (0.3%). Net sales are distributed geographically as follows: the United States (56%), the United Kingdom (4.5%), Europe/Middle East/Africa (21.8%), China (8.3%), Asia/Pacific (6.3%) and other (3.1%).
Employees
3,100
Date Price Change Volume
17/07/26 $72.12 +0.49% 3,076,479
16/07/26 $71.77 +0.41% 3,424,545
15/07/26 $71.48 +0.35% 3,187,304
14/07/26 $71.23 -0.18% 3,000,988
13/07/26 $71.36 +0.08% 2,176,717
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
72.12USD
Average target price
70.00USD
Spread / Average Target
-2.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TECH Stock